Vident Investment Advisory’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
2020
Q3
$1.06M Sell
2020
Q2
$1.41M Buy
2019
Q2
Sell
2019
Q1
$1.24M Sell
2018
Q4
$1.72M Buy
2018
Q3
$2.61M Sell
2018
Q2
$2.44M Sell
2018
Q1
$2.87M Buy
2017
Q4
$1.13M Sell
2017
Q3
$2.06M Buy
2017
Q2
$1.09M Buy
2017
Q1
$1.28M Buy
2016
Q4
$785K Buy
2016
Q3
$516K Sell
2016
Q2
$600K Sell
2016
Q1
$1.15K Buy
2015
Q4
$911K Buy